Sesen Bio, Inc. Contracts & Agreements

2024 Form of Stock Option Agreement (Filed With SEC on April 1, 2024)

Amended and Restated Open Market Sale AgreementSM, dated as of May 12, 2023, by and between the Company and Jefferies LLC (Filed With SEC on May 12, 2023)

Lease, dated April 22, 2019, by and between Wexford-SCEC 3675 Market Street, LLC and CARISMA Therapeutics Inc (Filed With SEC on May 11, 2023)

Registration Rights Agreement, dated March 7, 2023 (Filed With SEC on March 8, 2023)

Contingent Value Rights Agreement, dated March 7, 2023 (Filed With SEC on March 8, 2023)

Form of Indemnification Agreement for Directors and Officers of Carisma Therapeutics Inc (Filed With SEC on March 8, 2023)

Employment Agreement, dated March 7, 2023, by and between Carisma Therapeutics Inc. and Steven Kelly (Filed With SEC on March 8, 2023)

Employment Agreement, dated March 7, 2023, by and between Carisma Therapeutics Inc. and Richard Morris (Filed With SEC on March 8, 2023)

Employment Agreement, dated March 7, 2023, by and between Carisma Therapeutics Inc. and Michael Klichinsky (Filed With SEC on March 8, 2023)

CARISMA Therapeutics Inc. 2017 Stock Incentive Plan (Filed With SEC on March 8, 2023)

Form of Nonstatutory Stock Option Agreement under the CARISMA Therapeutics Inc. 2017 Stock Incentive Plan (Filed With SEC on March 8, 2023)

Form of Incentive Stock Option Agreement under the CARISMA Therapeutics Inc. 2017 Stock Incentive Plan (Filed With SEC on March 8, 2023)

Carisma Therapeutics Inc. Amended and Restated 2014 Stock Incentive Plan (Filed With SEC on March 8, 2023)

Form of Stock Option Agreement under the Carisma Therapeutics Inc. 2014 Amended and Restated Stock Incentive Plan (Filed With SEC on March 8, 2023)

Form of Restricted Stock Unit Agreement under the Carisma Therapeutics Inc. 2014 Amended and Restated Stock Incentive Plan (Filed With SEC on March 8, 2023)

Carisma Therapeutics Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on March 8, 2023)

Second Amendment to Agreement and Plan of Merger and Reorganization, dated as of February 13, 2023, by and among Sesen Bio, Inc., Seahawk Merger Sub, Inc., and CARISMA... (Filed With SEC on February 14, 2023)

Voting and Support Agreement, dated February 13, 2023, by and among the Radoff Family Foundation, Bradley L. Radoff, JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable... (Filed With SEC on February 14, 2023)

Collaboration and License Agreement, dated January 7, 2022, by and between Carisma and Moderna Therapeutics Inc (Filed With SEC on October 14, 2022)

License Agreement, dated as of November 10, 2017, by and between the Carisma and the Trustees of the University of Pennsylvania, as amended (Filed With SEC on October 14, 2022)

License Agreement, dated as of July 24, 2020, by and between the Carisma and New York University (Filed With SEC on October 14, 2022)

Asset Purchase Agreement, dated as of July 15, 2022 by and among Sesen Bio, Inc., F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Filed With SEC on July 18, 2022)

License Agreement, effective January 13, 2003, as amended and restated on October 14, 2015, by and between The University of Zurich and Viventia Bio Inc (Filed With SEC on May 9, 2022)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)

Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (Filed With SEC on February 28, 2022)

Form of RSU Award Agreement for Retention Awards (Filed With SEC on February 28, 2022)

Form of PSU Award Agreement for Retention Awards (Filed With SEC on February 28, 2022)

Amendment No (Filed With SEC on June 1, 2021)

Amendment No. 2 to the Sesen Bio, Inc. 2014 Stock Incentive Plan (Filed With SEC on May 3, 2021)

Amendment No. 1 to the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on May 3, 2021)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 15, 2021)

Amendment No. 2 to the Open Market Sale Agreement (Filed With SEC on February 17, 2021)

Exclusive License Agreement, dated July (Filed With SEC on November 9, 2020)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)

Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (Filed With SEC on March 16, 2020)

Open Market Sale AgreementSM, dated November 29, 2019, by and between Sesen Bio, Inc. and Jefferies LLC (Filed With SEC on November 29, 2019)

Employment Agreement, dated July 26, 2019, by and between Mark R. Sullivan and Sesen Bio, Inc (Filed With SEC on November 12, 2019)

Stock Option Award Agreement, dated August 1, 2019, by and between Sesen Bio, Inc. and Monica Forbes (Filed With SEC on November 12, 2019)

Form of 2017 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)

Form of 2017 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)

Form of 2018 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)

Form of 2018 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)

Amendment to Securities Purchase Agreement, dated October 28, 2019, by and among Sesen Bio, Inc. and the undersigned parties thereto (Filed With SEC on October 29, 2019)

Employment Agreement, dated August 26, 2019, by and between Monica Forbes and Sesen Bio, Inc (Filed With SEC on August 26, 2019)

Form of Indemnification Agreement, by and between Sesen Bio, Inc. and each of its directors and executive officers (Filed With SEC on August 26, 2019)

Press Release, dated August 26, 2019 (Filed With SEC on August 26, 2019)

Employment Agreement, dated September 20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen MacDonald, as amended on February 21, 2017 (Filed With SEC on August 8, 2019)

Separation and General Release, dated August 2, 2019, by and between Sesen Bio, Inc. and Dennis Kim (Filed With SEC on August 8, 2019)

Consulting Agreement, dated August 2, 2019, by and between Sesen Bio, Inc. and Dennis Kim (Filed With SEC on August 8, 2019)

2014 Stock Incentive Plan, as amended (Filed With SEC on June 25, 2019)

Underwriting Agreement, dated June 19, 2019 (Filed With SEC on June 19, 2019)

Form of Warrant (Filed With SEC on June 19, 2019)

Employment Agreement, dated September 20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen MacDonald, as amended on February 21, 2017 (Filed With SEC on May 10, 2019)

Stock Option Award Agreement, dated August 7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell, D.V.M (Filed With SEC on March 1, 2019)

Stock Option Award Agreement, dated December 3, 2018, by and between Sesen Bio, Inc. and Dennis Kim, M.D (Filed With SEC on March 1, 2019)

Master Bioprocessing Services Agreement, dated October 4, 2018, between Sesen Bio, Inc. and FUJIFILM Diosynth Biotechnologies U.S.A., Inc (Filed With SEC on March 1, 2019)

Employment Agreement, dated December 3, 2018, by and between Sesen Bio, Inc. and Dennis Kim, M.D., MPH (Filed With SEC on December 4, 2018)

Form of Indemnification Agreement by and between Sesen Bio, Inc. and each of its directors and executive officers (Filed With SEC on December 4, 2018)

Separation Agreement and General Release between Stephen Hurly and Sesen Bio, Inc (Filed With SEC on October 1, 2018)

Employment Agreement, dated August 7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell (Filed With SEC on August 13, 2018)

Form of Indemnification Agreement by and between Sesen Bio, Inc. and each of its directors and executive officers (Filed With SEC on August 13, 2018)

Underwriting Agreement, dated May 30, 2018 (Filed With SEC on June 1, 2018)

Consulting Agreement, dated October 20, 2017, by and between Eleven Biotherapeutics, Inc. and John J. McCabe (Filed With SEC on April 2, 2018)

Consulting Agreement, dated October 24, 2017, by and between Eleven Biotherapeutics, Inc. and DeCillis Consulting, LLC (Filed With SEC on April 2, 2018)

Placement Agent Agreement, dated as of March 21, 2018 by and between Eleven Biotherapeutics, Inc. and Laidlaw & Company (UK) Ltd (Filed With SEC on March 23, 2018)

Form of Warrant (Filed With SEC on March 23, 2018)

Form of Securities Purchase Agreement (Filed With SEC on March 23, 2018)

Employment Agreement, dated January 23, 2018, by and between Eleven Biotherapeutics, Inc. and Richard Fitzgerald (Filed With SEC on January 25, 2018)

Underwriting Agreement, dated as of November 1, 2017, by and between Eleven Biotherapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 3, 2017)

Form of Pre-funded Warrant (Filed With SEC on November 3, 2017)

Form of Common Warrant (Filed With SEC on November 3, 2017)

Form of Underwriting Agreement (Filed With SEC on October 31, 2017)

Form of Pre-Funded Warrant (Filed With SEC on October 31, 2017)

Form of Common Warrant (Filed With SEC on October 31, 2017)

Form of Underwriting Agreement (Filed With SEC on October 30, 2017)

Form of Pre-Funded Warrant (Filed With SEC on October 30, 2017)

Form of Common Warrant (Filed With SEC on October 30, 2017)

Form of Underwriting Agreement (Filed With SEC on October 17, 2017)

Consulting Agreement, effective as of October 13, 2017, by and between Eleven Biotherapeutics, Inc. and Richard F. Fitzgerald (Filed With SEC on October 13, 2017)

AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISES (Filed With SEC on November 14, 2016)

SHARE PURCHASE AGREEMENT by andamong ELEVEN BIOTHERAPEUTICS, INC., VIVENTIA BIO INC., THESHAREHOLDERS OF VIVENTIA BIO INC. (NAMED HEREIN) AND SOLELY IN ITS CAPACITY ASSELLER... (Filed With SEC on September 21, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 21, 2016)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on September 21, 2016)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED & RESTATED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on September 21, 2016)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on September 21, 2016)

ALMAD INVESTMENTS LIMITED (hereinafter called the Landlord), (Filed With SEC on September 21, 2016)

- 2 - (Filed With SEC on September 21, 2016)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on August 12, 2016)

License Agreement (Filed With SEC on June 13, 2016)

CONSENT AND THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 25, 2016)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 25, 2016)

Eleven Biotherapeutics, Inc. Restricted Stock Unit Agreement Granted Under 2014 Stock Incentive Plan NOTICE OF GRANT (Filed With SEC on June 29, 2015)

SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on December 19, 2014)

WARRANT TO PURCHASESTOCK (Filed With SEC on December 19, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 1, 2014)

ELEVEN BIOTHERAPEUTICS, INC. (A corporation existing under the laws of the State of Delaware) (Filed With SEC on December 1, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 1, 2014)

Eleven Biotherapeutics, Inc. (Filed With SEC on January 23, 2014)

ELEVEN BIOTHERAPEUTICS, INC. 2014 STOCK INCENTIVE PLAN (Filed With SEC on January 23, 2014)

Eleven Biotherapeutics, Inc. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on January 23, 2014)

Eleven Biotherapeutics, Inc. Non-statutory Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on January 23, 2014)

INDEMNIFICATION AGREEMENT (Filed With SEC on January 23, 2014)

ELEVEN BIOTHERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 23, 2014)

ELEVEN BIOTHERAPEUTICS, INC. Restricted Stock Agreement (Filed With SEC on January 23, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on January 23, 2014)

AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on December 30, 2013)

ELEVEN BIOTHERAPEUTICS, INC. Amended and Restated 2009 Stock Incentive Plan (Filed With SEC on December 30, 2013)

INCENTIVE STOCK OPTION Granted by ElevenBiotherapeutics, Inc. (the Company) Under the 2009 Stock Incentive Plan (Filed With SEC on December 30, 2013)

NON-STATUTORY STOCK OPTION Granted by ElevenBiotherapeutics, Inc. (the Company) Under the 2009 Stock Incentive Plan (Filed With SEC on December 30, 2013)

RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2013)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 30, 2013)

LEASE AGREEMENT (Filed With SEC on December 30, 2013)

Category

Industry

Companies

Contracts

Sesen Bio, Inc. Contracts & Agreements